Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 13Completed 12Active not recruiting 12Terminated 3Suspended 2Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 12Gastrointestinal 9Lymphoid 6Plasma cell 3Myeloid 3Head & Neck 3Genitourinary 3Breast 3Sarcoma 2CNS 2Thoracic 1Gynecologic 1

Conditions

Neuroblastoma 1Ganglioneuroblastoma 1Brain Neoplasms 1

Interventions

Temozolomide 20Magnetic Resonance Spectroscopy 10Radiotherapy 9Blood Specimen Collection 8pembrolizumab 6Cyclophosphamide 6Bevacizumab 6AZD 6244 6Radiation 5Specimen Handling 4vorasidenib 3fludarabine 3cemiplimab 3aflutinib 3Surgical Procedures, Operative 3Saline Solution 3Radiotherapy, Intensity-Modulated 3Radiosurgery 3Pemetrexed 3Granulocyte-Macrophage Colony-Stimulating Factor 3tislelizumab 2osimertinib 2naxitamab 2gallium maltolate 2fludarabine phosphate 2dinutuximab 2Topotecan 2Standard of Care 2Spinal Puncture 2Receptors, Interleukin-8B 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Biopsy × CNS × Clear all
NCT07437963 2026-04-15

Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

National Cancer Institute (NCI)

Phase 1/2 Not yet recruiting
76 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

NCT07039760 2026-03-11

Asciminib With or Without Sildenafil for Brain Tumors

Washington University School of Medicine

Phase EARLY_PHASE1 Not yet recruiting
12 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡